Results 111 to 120 of about 53,405 (189)

PIK3C2A is a gene-specific target of microRNA-518a-5p in imatinib mesylate-resistant gastrointestinal stromal tumor

Laboratory Investigation, 2016
Yuan Shi, Xiaodong Gao, Q. Hu, Xiaojing Li, Jian-fang Xu, Shaohua Lu, Ya-lan Liu, Chen Xu, D. Jiang, Jiaqian Lin, A. Xue, Yun-shan Tan, K. Shen, Yingyong Hou   +13 more
semanticscholar   +1 more source

Toxicity assessment of imatinib mesylate and a related impurity: in vitro and in vivo approaches. [PDF]

Toxicol Res (Camb)
Rocha CFRDS, Hermmann BS, Kayser JM, Zimmermann Prado Rodrigues G, Gehlen G, Boaretto FBM, Picada JN, Fleck JD, Charão MF, Verza SG.   +9 more
europepmc   +1 more source

Imatinib Mesylate-Induced Acquired Dermal Melanocytosis and Acquired Bilateral Nevus of Ota-Like Macules. [PDF]

Ann Dermatol, 2021
Jang JW, Song CH, Jung YJ, Cheon DU, Koh WS, Ro YS, Ko JY.   +6 more
europepmc   +1 more source

Claudin-1 Contributes to Gastrointestinal Stromal Tumors (GIST) Resistance to Imatinib Mesylate (IM) via Regulation of FGFR-Signaling. [PDF]

Int J Mol Sci
Boichuk S, Bikinieva F, Dunaev P, Galembikova A, Mikheeva E, Valeeva E, Mani S, Khromova N, Kopnin P, Shigapova L, Deviatiiarov R, Shagimardanova E, Ryzhkin S, Sabirov A.   +13 more
europepmc   +1 more source

Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adverse Events in Comparison with the Conventional Therapy with Vinblastine and Prednisone. [PDF]

Cells, 2022
Macedo TR, de Queiroz GF, Casagrande TAC, Alexandre PA, Brandão PE, Fukumasu H, Melo SR, Dagli MLZ, Pinto ACBCF, Matera JM.   +9 more
europepmc   +1 more source

Imatinib mesylate promotes melanogenesis through the modulation of p38 and MITF in murine cells. [PDF]

Toxicol Res
Talapphet N, Kim MM.
europepmc   +1 more source

Erythema following imatinib mesylate [PDF]

British Journal of Haematology, 2003
Duncan, E, Raj, K, Mufti, G
openaire   +2 more sources

Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndrome. [PDF]

Br J Haematol
Kim DH, Kim S, Park S, Byun JM, Hong J, Shin DY, Kim I, Bang SM, Lee JO, Lee JY, Kim SA, Kim KH, Chung YJ, Jung SH, Koh Y, Yoon SS.   +15 more
europepmc   +1 more source

In Vivo Efficacy of Imatinib Mesylate, a Tyrosine Kinase Inhibitor, in the Treatment of Chemically Induced Dry Eye in Animal Models. [PDF]

Transl Vis Sci Technol, 2021
Baek YY, Sung B, Choi JS, Go HK, Kim DH, Hyon JY, You JC.   +6 more
europepmc   +1 more source

Effect of Imatinib Mesylate on the Ovarian Reserves of Female Patients with Chronic Myeloid Leukaemia. [PDF]

Indian J Hematol Blood Transfus
Satija T, Suri V, Arora A, Gupta N, Sachdeva N, Jain A, Malhotra P.   +6 more
europepmc   +1 more source